Bayer Integrates Contrast Media Business into New Unit

David Rosenfeld | | Radiology Business | Business Intelligence
Bayer Healthcare announced a new business unit this week at the European Congress of Radiology (ECR) 2012 meeting in Vienna. The new unit, called Radiology and Interventional, combines businesses under the Bayer subsidiary Medrad and Bayer Healthcare Pharmaceutical’s own contrast media products, according to a press release. Bayer acquired Medrad in 2006 as part of the purchase of Schering AG. Medrad maintained its brand name after selling to Schering in 1995. The company was a leader in angiography and contrast material since 1964. “Working over several decades, the groups that now form Bayer HealthCare, Radiology and Interventional have achieved significant success in the radiology, interventional and contrast media fields,” said Joerg Reinhardt MD, chairman of the board of management of Bayer HealthCare, based on the release. “Our commitment continues with the integration of these business groups to increase focus on shared customers.”

David Rosenfeld

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.